Learn More
Medchemexpress LLC Tat-cyclo-cllfvy | 1446322-66-2 | 98.8% | 2559.08 | 1 MG

Supplier: Medchemexpress LLC HYP14201MG
TAT-cyclo-CLLFVY is a cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. It disrupts HIF-1α/HIF-1β protein-protein interaction with an IC50 of 1.3 μM.
- Cyclic peptide inhibitor of HIF-1 heterodimerization
- Inhibits hypoxia signaling in cancer cells
- Disrupts HIF-1α/HIF-1β protein-protein interaction
- Inhibits HIF-1 activity in mammalian cell luciferase reporter assay
- Powder storage: -80°C for 2 years, -20°C for 1 year
- In solvent storage: -80°C for 6 months, -20°C for 1 month
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.